Indocyanine Green Fluorescence-Guided Surgery in Pediatric Hepatobiliary Procedures: A Feasibility Study for Improved Intraoperative Visualization

Abstract

Introduction Indocyanine green (ICG) fluorescence-guided surgery (FGS) is reported extensively in adult operations, but its safety and applications in pediatric populations remain to be comprehensively understood. The dose, administration protocols, and intraoperative imaging benefits in pediatric hepatobiliary operations are not clear.

Objectives This study aimed to identify the feasibility and applications of ICG FGS in hepatobiliary surgeries (for biliary atresia, choledochal cyst, and cholelithiasis) in children.

Methods This is a prospective observational study conducted from January 2021 to December 2022. A standard ICG dose of 0.5 mg/kg/dose was administered intravenously to children undergoing operations for biliary atresia (18–24 hours), choledochal cyst (12–18 hours), and cholelithiasis (2–6 hours) before the operation. Intraoperative imaging features and adverse events were recorded.

Results ICG FGS was performed in 17 patients. In biliary atresia (n = 9), liver fluorescence varied in each case, the gallbladder did not show fluorescence, and there was increasing fluorescence as we reached the right depth during the excision of fibrous biliary remnants. In choledochal cyst (n = 6) operations and cholecystectomy (n = 2), real-time imaging provided anatomical details of the biliary tree and helped in safe dissection. No ICG-related adverse events occurred.

Conclusion ICG FGS appears safe, feasible, and beneficial in pediatric hepatobiliary surgeries. For conditions like biliary atresia, choledochal cysts, and cholecystectomy, ICG facilitates safer surgical navigation and may reduce intraoperative complications. Future studies with standardized protocols and quantitative fluorescence assessment are needed to further refine its use and confirm its impact on surgical outcomes.

Keywords

indocyanine green - fluorescence-guided surgery - pediatric hepatobiliary surgery

Publication History

Received: 03 May 2024

Accepted: 02 January 2025

Accepted Manuscript online:
03 January 2025

Article published online:
06 February 2025

• References

• 1 Jacob TJK, Thomas G. Indocyanine green beyond quantitative liver function tests – An adjuvant in pediatric imaging: a review of its uses and a protocol for administration in pediatric surgical practice. Curr Med Issues 2021; 19 (01) 42
• 2 Lau CT, Au DM, Wong KKY. Application of indocyanine green in pediatric surgery. Pediatr Surg Int 2019; 35 (10) 1035-1041
• 3 Todani T, Toki A. [Cancer arising in choledochal cyst and management]. Nippon Geka Gakkai Zasshi 1996; 97 (08) 594-598
• 4 Watanabe Y, Toki A, Todani T. Bile duct cancer developed after cyst excision for choledochal cyst. J Hepatobiliary Pancreat Surg 1999; 6 (03) 207-212
• 5 Flum DR, Koepsell T, Heagerty P, Sinanan M, Dellinger EP. Common bile duct injury during laparoscopic cholecystectomy and the use of intraoperative cholangiography: adverse outcome or preventable error?. Arch Surg 2001; 136 (11) 1287-1292
• 6 Giger UF, Michel JM, Opitz I, Th Inderbitzin D, Kocher T, Krähenbühl L. Swiss Association of Laparoscopic and Thoracoscopic Surgery (SALTS) Study Group. Risk factors for perioperative complications in patients undergoing laparoscopic cholecystectomy: analysis of 22,953 consecutive cases from the Swiss Association of Laparoscopic and Thoracoscopic Surgery database. J Am Coll Surg 2006; 203 (05) 723-728
• 7 Miura da Costa K, Saxena AK. Complications in pediatric laparoscopic cholecystectomy: systematic review. Updates Surg 2021; 73 (01) 69-74
• 8 Lambie H, Cook AM, Scarsbrook AF, Lodge JPA, Robinson PJ, Chowdhury FU. Tc99m-hepatobiliary iminodiacetic acid (HIDA) scintigraphy in clinical practice. Clin Radiol 2011; 66 (11) 1094-1105
• 9 Esposito C, Alberti D, Settimi A. et al. Indocyanine green (ICG) fluorescent cholangiography during laparoscopic cholecystectomy using RUBINA™ technology: preliminary experience in two pediatric surgery centers. Surg Endosc 2021; 35 (11) 6366-6373
• 10 Matsumura M, Kawaguchi Y, Kobayashi Y. et al. Indocyanine green administration a day before surgery may increase bile duct detectability on fluorescence cholangiography during laparoscopic cholecystectomy. J Hepatobiliary Pancreat Sci 2021; 28 (02) 202-210
• 11 Hirayama Y, Iinuma Y, Yokoyama N. et al. Near-infrared fluorescence cholangiography with indocyanine green for biliary atresia. Real-time imaging during the Kasai procedure: a pilot study. Pediatr Surg Int 2015; 31 (12) 1177-1182
• 12 Yanagi Y, Yoshimaru K, Matsuura T. et al. The outcome of real-time evaluation of biliary flow using near-infrared fluorescence cholangiography with Indocyanine green in biliary atresia surgery. J Pediatr Surg 2019; 54 (12) 2574-2578
• 13 Zhao J, Zhang Y, Jin Y. et al. Exploratory application of indocyanine green quantification in biliary atresia observational study. Photodiagnosis Photodyn Ther 2022; 39: 102960
• 14 García-Hernández C, Cabrera-González H, Carvajal-Figueroa L, Archivaldo-García C, Valero-Mamani RJ, Martinez-Flores RA. Usefulness of indocyanine green fluorescence in laparoscopic resection of choledochal cyst in children. J Pediatr Surg Case Rep 2022; 76: 102129
• 15 Daskalaki D, Fernandes E, Wang X. et al. Indocyanine green (ICG) fluorescent cholangiography during robotic cholecystectomy: results of 184 consecutive cases in a single institution. Surg Innov 2014; 21 (06) 615-621
• 16 Esposito C, Settimi A, Cerulo M, Escolino M. Efficacy of indocyanine green (ICG) fluorescent cholangiography to improve intra-operative visualization during laparoscopic cholecystectomy in pediatric patients: a comparative study between ICG-guided fluorescence and standard technique. Surg Endosc 2022; 36 (06) 4369-4375
• 17 Esposito C, Settimi A, Del Conte F. et al. Image-guided pediatric surgery using indocyanine green (ICG) fluorescence in laparoscopic and robotic surgery. Front Pediatr 2020; 8: 314
• 18 Shirota C, Hinoki A, Togawa T. et al. Intraoperative indocyanine green fluorescence cholangiography can rule out biliary atresia: a preliminary report. Front Pediatr 2022; 10: 1005879
• 19 Kubota A, Okada A, Fukui Y, Kawahara H, Imura K, Kamata S. Indocyanine green test is a reliable indicator of postoperative liver function in biliary atresia. J Pediatr Gastroenterol Nutr 1993; 16 (01) 61-65
• 20 Lisotti A, Azzaroli F, Buonfiglioli F. et al. Indocyanine green retention test as a noninvasive marker of portal hypertension and esophageal varices in compensated liver cirrhosis. Hepatology 2014; 59 (02) 643-650
• 21 Ainsworth AP, Axelsen AR, Rasmussen L. Cholecystectomy in children. Dan Med Bull 2010; 57 (11) A4201
• 22 Kim HY, Kim SH, Cho YH. Pediatric cholecystectomy: clinical significance of cases unrelated to hematologic disorders. Pediatr Gastroenterol Hepatol Nutr 2015; 18 (02) 115-120
• 23 Esposito C, Rathod KJ, Cerulo M. et al. Indocyanine green fluorescent cholangiography: the new standard practice to perform laparoscopic cholecystectomy in pediatric patients. A comparative study with conventional laparoscopic technique. Surgery 2024; 175 (02) 498-504
• 24 Broderick RC, Lee AM, Cheverie JN. et al. Fluorescent cholangiography significantly improves patient outcomes for laparoscopic cholecystectomy. Surg Endosc 2021; 35 (10) 5729-5739
• 25 Hope-Ross M, Yannuzzi LA, Gragoudas ES. et al. Adverse reactions due to indocyanine green. Ophthalmology 1994; 101 (03) 529-533
• 26 Breuking EA, van Varsseveld OC, Harms M, Tytgat SHAJ, Hulscher JBF, Ruiterkamp J. Safety and feasibility of indocyanine green fluorescence angiography in pediatric gastrointestinal surgery: a systematic review. J Pediatr Surg 2023; 58: 1534-1542